Background: Metastatic tumor cells spread through lymphatic vessels and colonize draining lymph nodes (LNs). It is known that tumors induce lymphangiogenesis to enhance lymphatic metastasis and that metastatic cancer cells are carried by lymph flow to LNs. Methods and Results: Here, we investigated the molecular and cellular regulation of collecting lymphatic vessel contraction in vessels draining a metastatic tumor using intravital microscopy. In tumor-draining collecting lymphatic vessels, we found vessel contraction was suppressed. The infiltration of peritumor tissue by inducible nitric oxide synthase positive and CD11b+Gr1+ myeloid cells played a critical role in the suppression of lymphatic contraction. Depletion of Gr1+ cells with an anti-Gr1 antibody improved contraction of tumor-draining lymphatic vessels. In addition, inducing tumor cell death restored lymphatic contraction in nude mice. Conclusions: These findings indicate that tumors contribute to regulation of lymphatic transport in a reversible manner, warranting further investigation into the role of impaired lymphatic transport in cancer progression.
Background: Metastatic tumor cells spread through lymphatic vessels and colonize draining lymph nodes (LNs). It is known that tumors induce lymphangiogenesis to enhance lymphatic metastasis and that metastatic cancer cells are carried by lymph flow to LNs. Methods and Results: Here, we investigated the molecular and cellular regulation of collecting lymphatic vessel contraction in vessels draining a metastatic tumor using intravital microscopy. In tumor-draining collecting lymphatic vessels, we found vessel contraction was suppressed. The infiltration of peritumor tissue by inducible nitric oxide synthase positive and CD11b+Gr1+ myeloid cells played a critical role in the suppression of lymphatic contraction. Depletion of Gr1+ cells with an anti-Gr1 antibody improved contraction of tumor-draining lymphatic vessels. In addition, inducing tumor cell death restored lymphatic contraction in nude mice. Conclusions: These findings indicate that tumors contribute to regulation of lymphatic transport in a reversible manner, warranting further investigation into the role of impaired lymphatic transport in cancer progression.
Authors: Valeriya P Makarenkova; Vishal Bansal; Benjamin M Matta; Lori Ann Perez; Juan B Ochoa Journal: J Immunol Date: 2006-02-15 Impact factor: 5.422
Authors: Petri Bono; Veli-Matti Wasenius; Päivi Heikkilä; Johan Lundin; David G Jackson; Heikki Joensuu Journal: Clin Cancer Res Date: 2004-11-01 Impact factor: 12.531
Authors: D Massi; S Puig; A Franchi; J Malvehy; S Vidal-Sicart; M González-Cao; G Baroni; S Ketabchi; J Palou; M Santucci Journal: J Clin Pathol Date: 2006-02 Impact factor: 3.411
Authors: M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar Journal: Nat Med Date: 2001-02 Impact factor: 53.440
Authors: Tatiana V Petrova; Terhi Karpanen; Camilla Norrmén; Russell Mellor; Tomoki Tamakoshi; David Finegold; Robert Ferrell; Dontscho Kerjaschki; Peter Mortimer; Seppo Ylä-Herttuala; Naoyuki Miura; Kari Alitalo Journal: Nat Med Date: 2004-08-22 Impact factor: 53.440
Authors: Jeroen Hagendoorn; Timothy P Padera; Satoshi Kashiwagi; Naohide Isaka; Fatima Noda; Michelle I Lin; Paul L Huang; William C Sessa; Dai Fukumura; Rakesh K Jain Journal: Circ Res Date: 2004-06-10 Impact factor: 17.367
Authors: Noa Schwartz; Madhavi Latha S Chalasani; Thomas M Li; Zhonghui Feng; William D Shipman; Theresa T Lu Journal: Front Immunol Date: 2019-03-20 Impact factor: 7.561